Moreover, we demonstrated that dasatinib treatment effectively ameliorated inflammatory manifestations in SP-induced acute lung injury in mice, characterized by the increased levels of IL-1α, IL-1β, CXCL1, neutrophils, and M1 macrophages. Here, IL1A is linked to injury.